Back to comparisons

Comparison

Bacopa Monnieri vs Panax Ginseng (Korean)

FieldBacopa MonnieriPanax Ginseng (Korean)
Categoryadaptogenadaptogen
Dose range300–600mg200–400mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs5401100

The comparison in plain English

Auto-generated from data

Bacopa Monnieri and Panax Ginseng (Korean) are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Panax Ginseng (Korean) Traditional Chinese/Korean adaptogen.

Bottom line

Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Panax Ginseng (Korean) (evidence B, safety 5/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Bacopa Monnieri if

Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.

Choose Panax Ginseng (Korean) if

Panax Ginseng (Korean) is the better fit when your goal aligns with its mechanism (Ginsenosides (the Panax-specific saponins) modulate HPA-axis cortisol response, support nitric oxide signalling in cerebral and peripheral vasculature, and have direct neuroprotective effects on hippocampal neurons) and the dose range (200–400mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →